Ligand Pharma (LGND)

Ligand Pharma (LGND) Cash flow


Ligand Pharma Cash Flow

LGND's free cash flow for Q2 2023 was $-285.00K. For the 2023 fiscal year, LGND's free cash flow was decreased by $49.89M and operating cash flow was $-82.00K. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ 107.83M$ 137.85M$ 78.80M$ 54.59M$ -29.34M$ 194.06M
Investing Cash Flow
$ 30.00M$ 163.62M$ 30.52M$ 231.65M$ 466.92M$ -423.27M
Financing Cash Flow
$ -114.66M$ -275.99M$ -137.76M$ -310.55M$ -485.17M$ 328.58M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 158.99M$ 45.01M$ 19.52M$ 47.96M$ 72.27M$ 119.78M
Income Tax Paid Supplemental Data
$ 11.62M$ 11.64M$ 3.72M$ 2.13M$ 103.82M$ 341.00K
Interest Paid Supplemental Data
$ 678.00K$ 1.43M$ 3.03M$ 4.46M$ 5.83M$ 1.51M
Issuance Of Capital Stock
Issuance Of Debt
$ -76.87M$ -261.00M$ -164.95M$ 0.00$ 0.00$ 750.00M
Repayment Of Debt
$ -114.53M$ -261.00M$ -164.95M$ -231.76M$ -27.32M$ -217.67M
Free Cash Flow
$ 97.79M$ 119.93M$ 70.04M$ 50.13M$ -31.89M$ 183.17M
Domestic Sales
Foreign Sales
Currency in USD

Ligand Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis